Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Qianren Biotechnology is a high-tech enterprise focused on the development and production of high-quality recombinant proteins, antibodies, and diagnostic reagents. Founded by experts from the Thousand Talents Plan, the company leverages advanced protein engineering and high-throughput expression platforms to serve the life sciences research and clinical diagnostics markets. Their product portfolio includes a wide range of cytokines, growth factors, and viral antigens used in vaccine development and disease detection. The company is headquartered in the Taizhou Medical High-tech Zone (China Medical City), where it maintains state-of-the-art R&D and manufacturing facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Qianren Biotechnology.